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The ability to deliver DNA molecules into the germline of dominance almost certainly arises out of our ever increasing mice by pronuclear injection revolutionized our ability to study ability to manipulate the murine germline. Over the past gene function. By selection of appropriate promoter and gene 20 years we have moved from a position where animal sequences it became possible to specifically address the role models arose either spontaneously or were generated of candidate genes by adding additional wild-type or mutant through exposure to carcinogen to a position in which it is copies to the germline. This approach has been extensively possible to create and study precise mutations of choice.
used to assess the heritable oncogenic potential of many The most recent advances in inducible and conditional different sequences. Early experiments addressed the tumourtechnologies now open the possibility for both temporal promoting activities of the SV40 T-antigen genes. When driven and tissue-specific gene manipulation. Each of these technoby the metallothionein promoter the SV40 early region genes logical breakthroughs has facilitated significant steps forwere demonstrated to strongly predispose to tumors within the ward in our understanding of the genetic basis of choroid plexus (4). By pairing down the construct used in tumorigenesis. This review will highlight some of the major these experiments, it became possible to identify the large T advances in the production and use of murine models of antigen as the key predisposing element within this transgene neoplasia over the last two decades.
(5), so establishing the T antigen as a potent oncogene. A number of similar experiments confirmed these findings for other tissues. For example, expression of the SV40 large T Modifying in the absence of transgenesis antigen was targeted to the pancreas both by use of rat insulin II (6) and elastase promoters (7). In both cases this resulted Prior to the ability to genetically manipulate the genome, animal models of neoplasia were principally based around the in tumours of the pancreas, respectively within the β-cells of the exocrine pancreas and in the acinar cells. Similar use of exposure of wild-type strains to carcinogen. This approach was clearly limited in its ability to analyse any genetic the α-crystallin promoter to drive expression of the T antigens in the lens was also shown to lead to tumour development (8). predisposition to disease. The first steps to resolve this problem did not strive to produce specific germline changes, but rather These and other experiments clearly established that transgenesis could be used to determine if a given sequence relied upon the use of germline mutagenesis to create strains with multiple random germline mutations. Use of N-ethyl-Npossessed true in vivo oncogenic activity. This opened the way for the rapid assessment of other candidate oncogenic nitrosourea (ENU) had been shown to cause a variety of base changes, including transitions and transversions, with rates of sequences, and in doing so generated a series of models of neoplastic disease. In this initial tranche of experiments many forward mutations quoted as high as one in 700 for specific genes (1). This approach was used by one laboratory to of these models did not perhaps reflect the true genetic basis of human disease, rather simply establishing the oncogenic generate a series of mutants affecting embryonic lethality and phenylalanine metabolism. Their phenotypic screen also potential of sequences irrespective of evidence implicating them in human disease. This is perhaps most clearly demonidentified mice characterized by anaemia, which was later shown to be a direct consequence of the development of strated by the widespread use of the SV40 large T antigen to drive tumorigenesis in, apparently, almost any murine multiple intestinal neoplasms (2).
This phenotype of this strain, now termed the Min (multiple tissue type.
Although the SV40 T antigen may not be directly associated intestinal neoplasms) mouse in view of its phenotype, closely resembled that of familial adenomatous polyposis patients, a with human disease, clearly this is not true of many of the targets of this protein. This was demonstrated by experiments syndrome characterized by multiple neoplasia and germline mutations of the APC gene. In due course, the mutation carried showing that retinal specific expression of the SV40 T antigen could mediate the development of retinoblastoma (9). These by the Min mouse was shown to be within the murine Apc gene (3), establishing the Min strain as an excellent genetic experiments achieved two important goals. First, they began to address the in vivo mechanisms of malignancy by showing model of human intestinal neoplasia.
The use of germline mutagenesis to generate the Min mouse that the oncogenic properties of the T antigen were at least partially dependent upon inactivation of the retinoblastoma demonstrated the validity of such an approach; however, this route has not been widely adopted as a method to model gene product, Rb. Secondly, they demonstrated the ability of transgenesis to deliver a specific genetic model of human was subsequently employed to identify Fgf3 and Fgf4 as cooperating oncogenes in mammary carcinogenesis (22). neoplasia.
Needless to say, this type of analysis was not confined to The use of addition transgenesis revolutionized our ability to understand both the inception of neoplasia and progression studies of the SV40 T antigen genes. In a parallel series of experiments several groups established a widespread role for of the disease. It should also be remembered that this approach has not been limited to the analysis of tumour promotion, but the c-Myc gene in malignancy. Expression of c-Myc under the control of the immunoglobulin µ or κ enhancers led to rapid has also been used to assess the ability of a given gene to actively suppress neoplasia, for example by directing expreslymphoma development (10). Use of the Thy-1 promoter delivered lymphoid and epithelial thymic tumours (11), and sion of the DNA repair gene O 6 -alkylguanine-DNA alkyltransferase to suppress thymic lymphomagenesis (23) . widespread expression of c-Myc using a mammary tumour virus LTR/c-Myc fusion transgene resulted in tumours in There are, however, a number of difficulties inherent in the creation and analysis of addition transgenics. First, there is multiple tissue types, including testicular, mammary and lymphoid lineages (12). Whilst establishing c-Myc as a potent little control over copy number of the transgene and there is no control over the transgene insertion site. These combine to in vivo oncogene, these experiments also began to illustrate the complex requirement for genetic change during malignancy, leave the investigator with limited control over the level and pattern of transgene expression, even with the use of extremely as it was apparent that tissue type influenced the ability of c-Myc to predispose to neoplasia. A further general conclusion well characterized promoters. Secondly, this approach is limited to the addition of genetic material. This does not absolutely could now be made in that transgene-driven neoplasia was normally a multistage process. For example, use of the immunopreclude the study of loss of gene function; for example, the phenotype of p53 deficiency has been addressed through the globulin heavy chain enhancer (E-µ) to drive c-Myc expression was shown to lead to aberrant B cell development, from which use of dominant-negative or gain-of-function mutants (24,25). However, such models will always retain the caveat that clonal lymphoid malignancies were ultimately assumed to result (13). This therefore delineated the effects of c-Myc proving total loss of function is extremely difficult. The advent of gene targeting technology, discussed below, has largely overexpression upon both differentiation and ultimate tumour predisposition, and in doing so implicated aberrant B cell circumvented these problems. differentiation in the early stages of carcinogenesis.
In order to further probe gene dependencies during neoplasia, Inducible transgenesis mice bearing multiple transgenic alleles were generated by intercrossing. This type of experiment rapidly identified synMany of the genetic changes that predispose to neoplasia mediate the over-expression of mutant or even wild-type ergy between different genes, and many such interactions have now been characterized. To take the example of c-Mycsequences. Conventional transgenic approaches have been used to model such genetic change with some success, ably mediated neoplasia, this has been shown to be markedly enhanced in a number of different transgenic backgrounds, demonstrated by the numerous experiments using c-Myc transgenes. However, using this approach temporal control over including those positive for Bcl-2, Bmi-1 and cyclin D1 (14-16).
The use of transgenic strains to identify co-operating events expression is usually determined by the characteristics of the promoter, and only becomes truly regulatable through the in malignancy has taken several different directions. In addition to the simple intercrosses described above, exposure to chemuse of inducible or suppressible promoters. Although some eukaryotic promoters could theoretically be used in this way ical carcinogen has been used. Here the concept was to use a given transgenic strain that shows a predisposition to malig-(for example the heat shock promoters) little progress has been made in their in vivo use. In the apparent absence of suitable nancy, to accelerate neoplasia by exposure to carcinogen and subsequently to screen for co-operating events. For example, eukaryotic promoters, several strategies have been adopted to regulate transgene expression. Perhaps the most widely used transgenic mice overexpressing the Pim-1 oncogene were characterized as predisposed to lymphoma. Additional expoof these is the two-component tetracycline system, which has been shown to mediate both tetracycline-dependent induction sure to the carcinogen ENU accelerated lymphomagenesis in this strain, and tumours that developed where characterized and repression of target sequences in mammalian cells in vitro (26) and in transgenics (27). This approach has had widespread by increased levels of c-Myc and mutations in ras (17,18). Such results strongly argue for co-operation between these in vitro application in the study of carcinogenesis; however, although examples of the in vivo use of this system do exist genes in neoplasia. An alternative approach has been to use viral integration to identify co-operating genes, termed 'proviral [for example, in the conditional transformation of pancreatic β-cells (28)], these are as yet relatively rare. One notable tagging'. This has again been used in a Pim-1 transgenic background, where infection with murine leukaemia virus recent exception to this has been the use of a suppressible H-Ras transgene to demonstrate an essential role for mutant resulted in accelerated lymphomagenesis and associated proviral activation of either c-Myc or N-Myc (19). Further evidence H-Ras in tumour maintenance (29) , and this may well herald the more widespread use of this technology. A similar situation for interaction between these genes was derived from, effectively, the inverse of this experiment, by using proviral tagging also pertains to use of the Ecdysone system, which exploits the Drosophila steroid-inducible ecdysone-responsive promoter in c-Myc transgenic animals to identify Pim-1 as one of four co-operating loci (20). (30) , and for which no in vivo application has yet been reported, at least in relation to tumour development. Finally, Use of proviral tagging has not been constrained to analysis of Pim-1 and c-Myc. The Wnt-1 locus was identified as a key use has been made of the ligand-binding domain of the estrogen receptor, in particular a tamoxifen-dependent mutation of target of activation during mammary tumorigenesis in wildtype mice by proviral insertion of the mouse mammary this region to confer steroid-dependent inducibility to fusion proteins. Here again, this system has been used extensively tumour virus. This association was subsequently tested by the development of Int-1 transgenic mice (21) and proviral tagging in vitro, for example to render expression of the c-Myc gene steroid dependent (31) , but use of this approach in vivo remains loop between these two genes (51 As demonstrated for the p53 gene, knockout strains have proven particularly potent tools in the analysis of tumour Gene targeting and gene knockouts suppressor genes. The list of genes analysed in this fashion now includes the retinoblastoma (Rb) gene (54-56), the Apc Two significant advances were made during the 1980s that enabled the precise engineering of the genome. The first of gene (57), the Neurofibromatosis genes Nf1 and Nf2 (58,59), the Brca1 and Brca2 genes (60-62) and the mismatch repair these was the development of cultures of murine embryonic stem cells, termed ES cells, which maintained their plurigenes Msh2, Mlh1, Pms1 and Pms2 (63, 64) . Although this list now include the majority of loci associated with human tumour potency in culture (32) , and which could be cloned and subsequently used to colonize the mouse germline (33) . The syndromes, it does not include a number of other genes that have become implicated in tumour suppression through their second was the demonstration that endogenous sequences could be exchanged, albeit initially at low frequencies, with knockout phenotype, such as α-inhibin (65). This fact in itself underlines how potent this form of analysis has become. homology maintained in plasmid vectors. This technology, termed homologous recombination or gene targeting, permitted
The generation of all these strains has allowed fundamental advances in our understanding of the mechanisms by which the exchange of subtly mutated cloned copies of a given gene with the endogenous allele (34,35). The ability of this approach these mutations predispose to malignancy. Often this has led to surprising results, as with the strains generated to analyse to direct mutations into an endogenous gene of choice was then demonstrated for ES cells (36) and finally for the germline Rb gene function. These showed that functional Rb was not absolutely essential for cell-cycle progression, as although of mice (37) .
Once gene targeting had established itself as a practical deficiency of Rb does lead to embryonic lethality, development up to day 12 of gestation is remarkably normal. Secondly, Rb methodology for accessing the germline of mice, there has been a rapid explosion in the number of murine strains mutants were found not to directly model human retinoblastoma in that heterozygotes failed to develop tumours of the retina, developed to study neoplasia. The first knockout of a tumour suppressor gene was of the p53 gene, created in 1992 (38) .
although they did succumb to tumours of the pituitary. This finding clearly identified a fundamental biological difference The development of this strain allowed the direct in vivo testing of a growing number of proposed roles for p53. Perhaps between mice and humans, and one which has been probed using intercrosses with mice mutant for other members of the the first major surprise, and one to be repeated for many other genes, was that the severity of the phenotype was not as retinoblastoma gene family. Thus, Rb heterozygotes crossed onto a p107-deficient background do develop multiple dyspredicted. Given the multiple proposed roles for p53 it was remarkable that the mutants survived to adulthood. p53 defiplastic lesions of the retina (66), a finding which has begun to unravel the tissue and species-dependent differences in the ciency was apparently fully compatible with normal development, although later analyses revealed a background dependent reliance upon different Rb family members. As with p53, and indeed all the other models generated, predisposition to neural tube defects (39, 40) . The rapid development of spontaneous tumours in these mice provided strong intercrosses to conventional transgenic and knockout strains have been used to probe Rb-dependent pathways. This type of support for an absolute role for p53 in tumour suppression. This was further supported by observations of p53 deficiency experiment can often yield apparently paradoxical results. Thus, inactivation of E2F-1, the transcriptional activity of accelerating carcinogen-induced liver neoplasia (41) and malignant progression in a chemically induced model of skin which Rb normally suppresses, was shown to predispose to tumorigenesis in a range of tissue types (67). However, carcinogenesis (42) . This strain was soon joined by other null mutations of p53 (43, 44) which displayed a similar tumour experiments using intercrosses with Rb heterozygotes and E2F-1 mutants confirmed the predicted requirement for predisposition and were used to probe the mechanisms underlying p53-dependent tumour suppression. For example, E2F-1 in Rb-mediated tumorigenesis (68). These results serve to underline both the strengths and potential difficulties of fibroblasts derived from mutant mice were used to confirm a role for p53 in cell-cycle arrest and in maintaining genomic transgenic analysis in the investigation of apparently simple pathways of gene dependency. stability (43) . These mice were also used to establish the in vivo role of p53 in inducing apoptosis following DNA damage (44-46), a role later also extended to hypoxia-mediated Refining the gene knockout approach cell death (47) .
The mechanisms underlying tumour suppression have perThe advent of gene targeting has clearly had a massive impact on our ability to relate gene function and dysfunction to haps been most extensively studied using the p53 mutant strains. Thus, we now know that p53 deficiency can co-operate carcinogenesis. This technology does, however, still possess several drawbacks. First, conventional targeting strategies leave with many other genetic alterations to promote neoplasia, such as with the SCID mutation (48), with mammary-specific a selection cassette within the targeted locus. This presents few problems if the aim is simply to inactivate the gene of expression of Wnt-1 (49), and with c-Myc (50) . Intercrossing of p53 mutants into other transgenic lines has also helped interest, but largely precludes the introduction of subtle mutations into the germline, and thereby the modelling of elucidate complex interactions between p53 and other genes. For example, p53 deficiency rescues embryonic lethality in point mutations in human disease. One solution has been to place the selection cassette into intronic sequences; however, Mdm2-deficient mice, reflecting the presence of a regulatory even this placement may influence gene expression. A number sites. This element is now in place for a number of different genes. Lox/frt flanked alleles have been reported for an SV40 of refinements have therefore been developed to address such problems. These rely on the use of multiple targeting steps to large T antigen transgene (76) and for endogenous alleles of Rb (77), Brca 1 (78) and Apc (79). To date, these have been introduce only the mutation of choice into the target locus. This route has been followed for a number of genes, including used in a largely confirmatory manner, for example by showing that intestinal deletion of Apc leads to rapid adenoma formation. the Hox genes (69) and the cystic fibrosis gene cftr-1 (70) . However, these approaches have as yet found little application Clearly, as the use of conditional alleles grows, this role will shift to a more fundamental analysis of gene function. This is in the study of neoplasia.
Perhaps the most serious drawback of conventional targeting already true for the Brca1 conditional allele, where mammary specific deletion has revealed a role in normal ductal morphois its inability to induce changes in the genome at specific times of development or in specific tissues. This is most genesis as well as in tumour suppression. The second requirement is for extremely tight control over limiting when constitutive loss of gene function leads to embryonic death, precluding any analysis of loss of function expression of the recombinase. Conventional transgenic strains have been created, wherein expression is tissue-and/or developin adult tissues. Furthermore, studies of carcinogenesis in a given tissue may be prevented because of the severity of mentally restricted, and these have been used effectively to study gene deletion, as in the Brca1 study mentioned above. phenotype in another cell type. Perhaps the clearest example of this is the rapid development of lymphoma in a number of This method does, however, suffer from all the drawbacks of conventional transgenesis, such that the current availability of different knockout strains generated primarily to study neoplasia of the intestine. Many of these problems may now have useful strains is somewhat limited. Several different groups have developed strategies that render cre expression condibeen overcome by the development of conditional targeting, discussed below. Another, simpler approach has been to tional, through use of the tetracycline system (80) or by use of the ligand-binding domain of the oestrogen receptor generate animals chimeric for wild-type and mutant cells. This can lead to the complete rescue of the lethal phenotype, as (81-83). An alternative approach has been to directly deliver the recombinase directly. This has been most efficiently demonoccurred when Rb null ES cells were used to generate adult chimeras (71, 72) . Alternatively, it can allow a dominant strated using adenovirus engineered to express recombinase (84, 85) . However, this approach is again subject to difficulties, phenotype to be studied that is otherwise incompatible with germline transmission, as occurred with a WT1 mutation principally associated with restricted delivery and host immune responses, and although it has been used (79) to study modelling Denys-Drash syndrome (73) .
carcinogenesis, its use is not yet widespread.
Conditional knockout alleles
Chromosomal rearrangements The drive to create truly conditional alleles came from a
The development of cre/flp technology has opened another number of different directions. Perhaps the most powerful approach to altering the genome, that of engineering at the incentive has been the high incidence of embryonic lethality level of the chromosome. Translocations and loss of heteroobserved in constitutive knockouts, which effectively precludes zygosity are key genetic events associated with neoplasia. The the analysis of gene function in adult tissues. Other reasons ability to use the cre-lox system to mediate defined deficiencies, include the difficulty that particular tissue types cannot be inversions, duplications or translocations was demonstrated properly studied in isolation, and the concern that developboth in ES cells and in the germline of mice by three different mental compensation may be occurring within some knockouts, groups (86) (87) (88) . Such macrogenetic changes can be shown to thereby complicating the phenotypic analysis.
predispose to tumorigenesis, for example of the thymus in In 1988, Sauer and Henderson demonstrated that the cre mice bearing a 1 Mb duplication of a portion of chromosome protein of bacteriophage P1 could be used in mammalian cells 11 (89). Perhaps the most interesting prospect for this to mediate recombination between two 34 bp sites termed loci technology is to use chemical mutagenesis in conjunction of recombination or 'lox' sites (74) . The result of cre-mediated with hemizygous chromosomal deletions to drive a relatively recombination is either the deletion or inversion of the rapid functional screen of the haploid areas so generated (90). sequences flanked by the lox sites, dependent on their orientation. One of the major advantages of this system, and of the Transgenic mice as reporters of carcinogenesis essentially equivalent Flp-frt system, is that no mammalian protein is capable of recognizing the lox sites, and background Many of the examples cited above have demonstrated how transgenic technology has enabled a better understanding of recombination in the absence of the cre recombinase is undetectable. Furthermore, the recombination event is an 'all the molecular basis of neoplasia. One remaining fundamental question is how useful such transgenic models are at directly or nothing' phenomenon, so partial or graded expression should not occur. The recognition that cre (or Flp)-mediated assessing the tumour preventative, mutagenic or carcinogenic properties of a given compound, and in determining the gene excision of lox (or frt)-flanked sequences could result in gene inactivation or upregulation (through deletion of inhibitory dependency of such predisposition. Studies of the impact of drug and genotype upon mutation rates have been facilitated sequences) provided a powerful solution to many of the difficulties linked to constitutive knockouts. The first in vivo by the development of transgenic strains that carry a LacZ transgene that can subsequently be rescued and scored for demonstration of this technology came in 1994 with the T-cell-specific knockout of the DNA polymerase β gene (75) . functional mutations. Use has been made of these strains to score spontaneous mutation rates in mutant strains, such as in In order for this technology to be applied to the study of neoplasia, two components were required. The first of these p53-deficient mice (91), and also following exposure to known or potential carcinogens (92). This type of study has been is the generation of appropriate lox/frt-flanked alleles which could be shown to be unaffected by the insertion of the lox subject to some criticism, principally because it uses a prokary-otic transgenic target in which mutation frequency is scored the development of gene-knockout strains, these can again be expected to revolutionize our ability to understand the genetic ex vivo; however, it has been shown to compare well with data collected for mutation at the Dlb-1 locus, the only widely control of neoplasia. used endogenous marker of in vivo mutation (93).
The precise relationship between mutagenesis and carcinoReferences genesis remains unresolved, and therefore transgenic strains sensitivity for such a role (97 using these models in this manner; however, some caution which can sometimes confound the analysis of mutant strains.
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These difficulties have, however, driven a rapid evolution in 
